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Physical activity, sedentary time and gain in overall and central
body fat: 7-year follow-up of the ProActive trial cohort
R Golubic1, K Wijndaele1, SJ Sharp1, RK Simmons1, SJ Grifﬁn1, NJ Wareham1, U Ekelund1,2 and S Brage1 on behalf of the ProActive
study group
OBJECTIVE: The objective of this study is to examine the independent associations of time spent in moderate-to-vigorous physical
activity (MVPA) and sedentary (SED-time), with total and abdominal body fat (BF), and the bidirectionality of these associations in
adults at high risk of type 2 diabetes.
DESIGN AND SUBJECTS: We measured MVPA (min per day) and SED-time (h per day) by accelerometry, and indices of total (body
weight, fat mass (FM), BF% and FM index) and abdominal BF (waist circumference (WC)) using standard procedures in 231 adults
(41.3 ± 6.4 years) with parental history of type 2 diabetes (ProActive UK) at baseline, 1-year and 7-year follow-up. Mixed effects
models were used to quantify the independent associations (expressed as standardised β-coefﬁcients (95% conﬁdence interval
(CI))) of MVPA and SED-time with fat indices, using data from all three time points. All models were adjusted for age, sex,
intervention arm, monitor wear time, follow-up time, smoking status, socioeconomic status and MVPA/SED-time.
RESULTS: MVPA was inversely and independently associated with all indices of total BF (for example, 1 s.d. higher MVPA was
associated with a reduction in FM, β=− 0.09 (95% CI: − 0.14, − 0.04) s.d.) and abdominal BF (for example, WC: β=− 0.07 (−0.12,
− 0.02)). Similarly, higher fat indices were independently associated with a reduction in MVPA (for example, WC: β=− 0.25 (−0.36,
− 0.15); FM: β=− 0.27 (−0.36, − 0.18)). SED-time was positively and independently associated with most fat indices (for example, WC:
β= 0.03 (−0.04, 0.09); FM: β= 0.10 (0.03, 0.17)). Higher values of all fat indices independently predicted longer SED-time (for
example, WC: β= 0.10 (0.02, 0.18), FM: β= 0.15 (0.07, 0.22)).
CONCLUSIONS: The associations of MVPA and SED-time with total and abdominal BF are bidirectional and independent among
individuals at high risk for type 2 diabetes. The association between BF and MVPA is stronger than the reciprocal association,
highlighting the importance of considering BF as a determinant of decreasing activity and a potential consequence. Promoting
more MVPA and less SED-time may reduce total and abdominal BF.
International Journal of Obesity (2015) 39, 142–148; doi:10.1038/ijo.2014.66
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INTRODUCTION
Type 2 diabetes mellitus (T2DM) and its complications constitute a
major public health burden and account for considerable
morbidity and mortality worldwide.1 Individuals with a family
history of T2DM are 2–6 times more likely to develop the disease
compared with those without.2 T2DM risk is additionally elevated
by physical inactivity3 and weight gain.4 There is accumulating
evidence that prolonged sedentary behaviour is an independent
risk factor for weight gain, obesity5,6 and other chronic diseases
such as cardiovascular disease7 and T2DM.5,8,9
Several prospective studies using self-reported physical activity
(PA) have shown inverse associations between total PA and
weight gain in the general population, but ﬁndings were
inconsistent and effect sizes were small.10 Less attention has
been given to individuals at increased risk for developing T2DM.
Furthermore, abdominal fat has been shown to be a stronger
predictor of several disease outcomes as compared with total
body fat (BF), including cardiovascular disease,11 T2DM12 and all-
cause mortality.13 However, there is limited data exploring the
association between PA at different intensity levels and abdominal
adiposity. In addition, studies using objective assessment of PA
and body composition are scarce and limited in terms of their
cross-sectional design14 and focus on sedentary time (SED-time),
whisch is deﬁned as time spent watching television or as no
participation in regular sports or strenuous PA.14,15 Finally,
although several cohort studies have examined the bidirection-
ality of this relationship and demonstrated that higher body mass
index (BMI) or body weight is associated with future physical
inactivity16,17 or longer time spent sedentary,15,18–20 none have
conﬁrmed that physical inactivity has long-term appreciable
effects on the development of obesity or increases in BMI.
A better understanding of the magnitude and direction of the
association between objectively measured components of PA
and BF in high-risk groups is needed to develop tailored PA
interventions. Using data from the ProActive study, we aimed to
examine the association between objectively measured
moderate-to-vigorous PA (MVPA), SED-time, and total and
abdominal BF at three time points (baseline, 1 year and 7 years
later). The possible bidirectionality of these associations was also
assessed.
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METHODS
Study design and population
ProActive is a randomised controlled trial of the efﬁcacy of an evidence-,
family- and theory-based intervention programme to increase PA among
individuals at high risk of T2DM, deﬁned as having a parental history of
T2DM.21 Full details of the study have been described elsewhere.21 In brief,
the offspring of T2DM patients, identiﬁed from either diabetes registers or
family history medical records in 20 UK general practices, were asked to
complete a short screening questionnaire to exclude very active
individuals.22,23 Of the 465 eligible individuals, 365 were randomly
assigned to one of the following three interventions24: brief written
advice (control group) or a behavioural change programme at two levels of
intensity delivered either by telephone (distance) or face-to-face in the
family home. As the main trial results showed no signiﬁcant effect on
1-year change in objectively measured daytime PA,24 the trial arms were
pooled and a cohort analysis was conducted. Participants with complete
data on objectively measured PA (baseline: n=240, 1 year: n= 233 and 7
years: n=250) were considered for this analysis. Those with missing data
on BF parameters were excluded (n= 9 at baseline, n=11 at 1 year and
n= 19 at 7 years). One participant became a wheel-chair user at 7 years and
was excluded. Therefore, the ﬁnal sample comprised n=231 at baseline,
n= 222 at 1 year and n= 230 at 7 years. All participants gave written
informed consent. Ethical approval was provided by the Cambridge
Central REC (reference number 09/110308/3), and the Declaration of
Helsinki was adhered to during all phases of the study. This trial is
registered as ISRCTN 61323766.
Assessment of PA
Free-living PA was measured with accelerometry (MTI Actigraph,
Manufacturing Technology, Fort Walton Beach, FL, USA) over four
consecutive days at baseline and follow-up time points, as previously
described.25 The Actigraph model WAM 7164 (ActiGraph LLC, Pensacola,
FL, USA) was used at baseline and 1-year follow-up, and model GT1M at
7-year follow-up. Both models provide an integrated measure of accelera-
tion and movement frequency,26–28 and a correction factor of 0.91 was
used to achieve comparability between the models (model 7164 =GT1M/
0.91).29 Participants wore the accelerometer on the lower back during
waking hours, except for water-based activities. Non-wear time was
deﬁned as continuous strings of zero lasting for >60min. Participants were
excluded if their monitor wear time did not exceed 500min per day for at
least 3 days (n= 41 at all measurement time points). Volume of activity was
considered to represent total PA and was calculated as total accumulated
activity counts divided by total wear time, expressed in counts per minute.
Average daily time spent sedentary, in light-intensity PA and in MVPA were
derived using o100 counts min− 1 (refs 25,30), 100–1951 and ⩾ 1952
counts min− 1 (ref. 31) cutoffs to summarise the movement intensity
time-series records, respectively. A customised programme was used for
data cleaning and reduction (MAHUffe, available from www.mrc-epid.cam.
ac.uk/resources).
Anthropometric measures
Body weight, height, hip and waist circumference (WC) were measured
according to identical standard operating procedures at all time points.
BMI was calculated as weight in kilograms divided by the square of height
in meters. Resistance was assessed using a standard bio-impedance
technique (Bodystat; Isle of Man, UK) with good reliability32 and validity.33
Total body water and fat-free mass (FFM) were calculated from published
equations34 using body weight and the impedance index (square of height
divided by resistance). Fat mass (FM) was computed as the difference
between body weight and FFM. BF% was calculated as FM divided by total
body weight. FM index (FMI) was computed as FM in kilograms divided by
the square of height in meters.
Self-reported covariates
Smoking status was categorised as current, former or never. Age at
completion of full-time education was considered as a proxy for socio-
economic status and analysed as a binary variable (below/above 16 years).
Statistical analysis
Descriptive statistics (means and standard deviations (SD)) at baseline and
follow-ups were calculated for the whole sample and for women and men
separately. T-tests were used to examine differences by sex, and
differences in baseline characteristics between those with and without
follow-up data and accelerometer data. Each PA variable and fat index was
regressed against follow-up time to assess the time trend for the whole
sample, and for women and men separately.
The associations between MVPA and SED-time with total and abdominal
BF were assessed using mixed effects regression models, including up to
three values of each exposure and outcome per person. The algebraic
equations used to model the associations under consideration are detailed
in Supplementary Appendix 1. No signiﬁcant interactions with sex were
found, so results are therefore presented for both sexes combined. Two
levels of adjustment were considered in the analysis. Model 1 was adjusted
for age (baseline), sex, trial group arm, monitor wear time, follow-up time,
smoking and socioeconomic status (baseline). To determine the trajectory
of the association over time, an interaction term with follow-up time was
added to Model 1, and the main effects of MVPA and SED-time on BF
indices after 1 year and 7 years were calculated (Model 1a). Model 2 was
adjusted for MVPA (when the exposure was SED-time) or SED-time (when
the exposure was MVPA) in addition to the covariates in Model 1. When
MVPA or SED-time was the outcome, FM, WC, BF% and FMI were included
as exposures in separate models adjusted for confounders as described
above. All exposure and outcome variables were standardised using means
and SDs of baseline values. Thus, the β-coefﬁcients represent the change in
the outcome (in s.d.’s) associated with a 1 s.d. change in the exposure. This
enabled direct comparisons of the effects of SED-time and MVPA on
different fat indices and vice versa under the assumption that the variables
were measured with the same degree of error. All statistical tests were two-
sided with signiﬁcance deﬁned as Po0.05. All analyses were completed
using STATA 13 (STATA, College Station, TX, USA).
RESULTS
Participant characteristics
Participant characteristics at baseline and follow-ups are
summarised in Table 1 for both sexes combined and separately
in men and women. Median (interquartile range (IQR)) follow-up
time was 7.4 (7.1–7.7) years. There was a signiﬁcant increase in
weight, BMI and fat indices over time in both sexes. Men had
signiﬁcantly higher weight, FFM, WC and lower FM, BF% and FMI
than women at all time points. In both sexes, average time in
MVPA was below 30min per day at all time points, and 70%, 64%
and 65% of participants did not meet current PA recommenda-
tions at baseline, 1-year and 7-year follow-up, respectively.3
Compared with women, men spent substantially more time in
both MVPA and sedentary. Pearson’s correlation coefﬁcients
between time spent in MVPA and sedentary were as follows:
r=− 0.14 (P= 0.036), r=− 0.18 (P= 0.007) and r=− 0.17 (P= 0.006)
for baseline, 1-year and 7-year follow-up, respectively, whereas the
corresponding correlations between time in light-intensity PA and
MVPA were r=0.09, r=0.24 and r=0.10 (all P>0.05). There was a
signiﬁcant negative correlation between time in light-intensity PA
and sedentary at all time points: r=− 0.64, r=− 0.64 and r=− 0.57
for baseline, 1-year and 7-year follow-up, respectively (all Po0.001).
The volume of activity (counts per minute) and time in MVPA were
strongly and positively correlated (r>0.8; Po0.001) at all time
points. Mean (s.d.) SED-time increased in both sexes from 8.1 (1.5) h
per day at baseline to 9.0 (1.7) h per day at the 7-year follow-up
(Po0.01). The mean proportion of wear time spent in MVPA was
between 3 and 4% at all time points in both sexes, whereas the
mean proportion spent sedentary ranged from 58 to 61% in women
and from 60 to 65% in men. Mean (s.d.) time at light-intensity PA at
baseline was 5.3 (1.2) h per day in the whole sample that remained
consistent over time and did not differ between the sexes.
There were no signiﬁcant differences in BF indices at baseline
between individuals with and without sufﬁcient accelerometer
information (data not shown). Participants with and without
complete follow-up data on PA and body composition were
comparable for all baseline characteristics, except for sex, with
more women with incomplete follow-up data (data not shown).
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Mixed effects regression models with BF indicators as outcomes
Table 2 shows the estimated associations of MVPA and
SED-time (exposures) with abdominal and total BF indices
(outcomes) from the mixed effects model. MVPA was inversely
associated with all adiposity indices, after adjustment for age, sex,
intervention arm, monitor wear time, follow-up time, smoking
status and socioeconomic status (Model 1). Standardised
β-coefﬁcients for MVPA ranged from − 0.07 (95% conﬁdence
interval (CI): − 0.10, − 0.03) for body weight to − 0.13 (95% CI:
− 0.18, − 0.08) for BF%, indicating an inverse association with all
outcomes. For weight, WC and FMI the size of the interaction
between MVPA and follow-up time was small (Model 1a) but
statistically signiﬁcant, suggesting that the inverse association
between MVPA and BF strengthened over time. For example,
the main effect (β (95% CI)) of MVPA on body weight at 1 year was
− 0.03 (−0.08, 0.02), and reached − 0.08 (−0.11, − 0.04) at 7 years.
This corresponds to a reduction in body weight of 0.5 kg
(95% CI: 0.2, 1.4) associated with 16.8 min per day increase in
MVPA at 1 year, and a reduction in body weight of 1.4 kg (95% CI:
0.7, 1.9) associated with that same increase in MVPA at 7 years.
The corresponding reductions in fat mass associated with the
same amount of MVPA were 0.67 kg (95% CI: 0.03, 1.33) at 1 year
and 1.2 kg (95% CI: 0.7, 1.7) at 7 years. Furthermore, the overall
effect of MVPA on BF indices was robust to adjustment for SED-
time, indicating independent associations with all adiposity
indicators (Model 2). A sensitivity analysis with light-intensity PA
as exposure (Models 1 and 2 adjusted for MVPA instead of SED-
time) yielded associations of similar magnitude and the same
Table 1. Participant characteristics at baseline, 1-year and 7-year follow-up in the ProActive trial cohort
Both sexes Baseline 1-year follow-up 7-year follow-up
N 231 222 230
Age (years) 41.3 (6.4) 42.6 (6.3) 48.7 (6.2)***
Weight (kg) 79.5 (17.0) 80.8 (16.8) 83.3 (17.5)*
BMI (kgm−2) 27.7 (4.9) 28.0 (4.9) 28.7 (5.1)*
Fat mass (kg) 25.1 (9.5) 25.3 (9.4) 26.4 (10.1)*
Fat-free mass (kg) 54.5 (11.6) 55.5 (11.7) 56.9 (12.6)*
WC (cm) 93.0 (13.4) 94.2 (13.2) 94.3 (13.9)**
BF% 31.0 (7.7) 30.9 (7.6) 31.3 (8.4)*
FMI (kgm−2) 8.9 (3.5) 8.9 (3.5) 9.2 (3.8)*
MVPA (min per day) 25.7 (16.8) 29.4 (19.4) 29.1 (21.3)
LPA (h per day) 5.2 (1.2) 5.1 (1.3) 4.8 (1.2)
Sedentary (h per day) 8.1 (1.5) 7.9 (1.6) 9.0 (1.7)**
Volume of activity (counts per min) 323.2 (114.6) 342.5 (125.3) 338.0 (136.4)
Monitor wear time (h per day) 13.7 (1.2) 13.5 (1.3) 14.4 (1.4)*
Women Baseline 1-year follow-up 7-year follow-up
N 139 126 130
Age (years) 41.3 (6.3) 42.9 (6.2) 48.9 (6.3)***
Weight (kg) 73.1 (14.7)††† 73.6 (14.1)††† 76.2 (15.2)***,†††
BMI (kgm− 2) 27.4 (5.2) 27.7(5.1) 28.5 (5.5)***
Fat mass (kg) 26.1 (10.2)† 26.3(9.9) 27.9 (10.8)**,††
Fat-free mass (kg) 47.0 (5.4)††† 47.2 (5.4)††† 48.3 (6.2)†††
WC (cm) 87.8 (12.0)††† 89.0 (12.0)††† 89.4 (13.3)**,†††
BF% 35.5 (7.0) ††† 34.7 (6.2)††† 35.5 (7.4)**,†††
FMI (kgm−2) 9.8 (3.8) ††† 9.9 (3.7)††† 10.5 (4.0)**,†††
MVPA (min per day) 23.6 (16.7)*** 28.2 (20.5) 24.7 (19.1)†††
LPA (h per day) 5.3 (1.2) 5.1 (1.2) 5.0 (1.1)
Sedentary (h per day) 7.8 (1.4)†† 7.8 (1.5) 8.6 (1.6)***,†††
Volume of activity (counts per min) 321.4 (117.3) 340.1 (122.8) 326.3 (130.3)*
Monitor wear time (h per day) 13.5 (1.2)††† 13.3 (1.3)† 14.0 (1.4) *,†††
Men Baseline 1-year follow-up 7-year follow-up
N 92 96 100
Age (years) 41.2 (6.4) 42.2 (6.3) 48.4 (6.0)***
Weight (kg) 89.3 (15.7) 90.2 (15.4) 92.4 (15.9)***
BMI (kgm− 2) 28.3 (4.5) 28.4 (4.5) 29.0 (4.5)***
Fat mass (kg) 23.5 (8.3) 23.9 (8.4) 24.9 (8.9)
Fat-free mass (kg) 65.8 (9.0) 66.3 (8.4) 68.1 (9.6)
WC (cm) 100.8 (11.6) 101.0 (11.4) 100.7 (12.2)
BF% 25.6 (5.3) 25.9 (5.2) 25.7 (6.1)
FMI (kgm− 2) 7.5 (2.6) 7.5 (2.6) 7.6 (2.8)
MVPA (min per day) 29.0 (16.6) 30.9 (17.8) 34.7 (22.8)
LPA (h per day) 5.1 (1.3) 5.1 (1.3) 4.7 (1.3)
Sedentary (h per day) 8.4 (1.4) 8.1 (1.6) 9.6 (1.7)**
Volume of activity (counts per min) 325.9 (111.0) 345.7 (129.0) 356.2 (143.2)
Monitor wear time (h) 14.0 (1.1) 13.7 (1.3) 14.8 (1.3)*
Abbreviations: BF%, percentage of body fat; BMI, body mass index; FMI, fat mass index (fat mass per height2); LPA, light-intensity physical activity; MVPA, time
spent in moderate-to-vigorous physical activity; WC, waist circumference. Results are mean (s.d.). N is the number of participants with complete data on all
variables in Table 1. *Po0.05, **Po0.01, ***Po0.001 time trend in the variable of interest (regression against follow-up time). †Po0.05, ††Po0.01,
†††Po0.001 for the difference between men and women at each time point (t-test).
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direction as those observed for MVPA, and there was no
interaction with follow-up time.
SED-time was signiﬁcantly positively associated with all fat
indices except WC, with standardised β-coefﬁcients ranging from
0.11 (95% CI: 0.06, 0.16) for body weight to 0.14 (95% CI: 0.08, 0.21)
for FM (Model 1; Table 2). Interactions between SED-time and
follow-up time (Model 1a) were not statistically signiﬁcant, so
there was no evidence that the effect of SED-time on the
outcomes changed over time. After additional adjustment for
MVPA (Model 2), the main effect of SED-time on BF indices was
somewhat attenuated but remained statistically signiﬁcant (except
for BF%), with the greatest attenuation (30%) where FMI was the
outcome. On the original scale, every additional 1.5 h per day
spent sedentary was associated with a 1.5 kg (95% CI: 0.7, 2.4)
increase in body weight independent of MVPA.
Mixed effects regression models with MVPA or SED-time as
outcomes
When MVPA was modelled as the outcome (Table 3), inverse
independent associations were consistently observed for all BF
indices, with an approximately threefold greater magnitude
compared with the relationships where MVPA was considered
the exposure variable (Table 2). Adjusted standardised
β-coefﬁcients ranged from β=− 0.25 (95% CI: − 0.36, − 0.15) for
WC to β=− 0.30 (95% CI: − 0.41, − 0.19) for BF%. Positive
associations were found between all adiposity indices and SED-
time as the outcome (Table 3), and were of a similar magnitude as
those observed in the models where SED-time was the exposure
(Table 2). No signiﬁcant interactions between the BF indices and
follow-up time were identiﬁed. In a sensitivity analysis with light-
intensity PA as outcome, standardised β-coefﬁcients were of
opposite direction and the same magnitude as compared with
those observed for SED-time.
DISCUSSION
This study used repeated measures over a 7-year period to assess
the associations between objectively measured time spent in
MVPA and sedentary with total and abdominal BF in middle-aged
adults with parental history of T2DM. We also assessed the extent
to which these associations changed over time and the
bidirectionality of the associations. Overall, our ﬁndings suggest
that MVPA and SED-time have substantial and independent
effects on both total and abdominal BF. A 1.5-h reduction in SED-
time and a 16-min increase in MVPA per day were associated with
a 1.4-kg and 0.5-kg reduction in body weight over 1 year,
respectively. There is evidence that MVPA exerts stronger
beneﬁcial effects on BF over time, which was not the case for
SED-time, whose detrimental effect did not vary signiﬁcantly over
time. There was a signiﬁcant inverse association between all fat
indicators and MVPA (outcome) that did not appear to vary over
time. This association was of approximately threefold greater
magnitude compared with the relationship of MVPA (exposure)
and BF (outcome). Similarly, we found a signiﬁcant positive
association between all BF indices and SED-time, and this
relationship remained stable over the follow-up. The effects of
BF seem to be stronger on MVPA than on SED-time. Taken
together, our analyses demonstrate bidirectional associations of
PA and sedentary behaviour with BF. Relative magnitude of the
association between BF and MVPA is greater than the reciprocal
association, thereby highlighting the importance of considering
BF as a determinant of decreasing activity as well a potential
consequence.
To the best of our knowledge, no previous studies have
examined the associations between MVPA, SED-time and using
objective methods to repeatedly assess exposure and outcome in
a population with a parental history of T2DM. A systematic review
of prospective cohort studies using objective assessment of PA
among children, adolescents and adults has shown that total PA
(expressed as counts per minute or as energy expenditure) is not a
predictor of weight gain.35 Among other studies that used
objective assessments of PA and body composition, Healy
et al.14,30 found a positive cross-sectional association between
SED-time and WC in the United States and Australian general
population samples. Ekelund et al.,15 on the other hand, did not
detect any signiﬁcant role of SED-time for predicting changes in
adiposity. The latter three studies, however, did not examine
individuals at high risk of T2DM and focused only on SED-time as
the exposure.
MVPA predicted WC in our sample, which is in keeping with the
results from a few large-scale epidemiological studies using total
PA.36–38 Although these studies used large sample sizes and have
a long follow-up, they are limited by their use of self-reported PA
measures, which might have led to misclassiﬁcation bias. Results
from the EPIC-PANACEA study indicate that low total PA predicts a
gain in abdominal adiposity in the general adult population from
10 European countries (N>280 000, age range 25–79 years at
baseline).36 Using a similar analytical approach as the current
analyses, May et al.38 demonstrated that inverse prospective
associations of total PA with gains in weight and WC in 4944
Table 2. Associations between time spent in MVPA and sedentary with fat indicators obtained from mixed effects models using data at all time
points in the ProActive trial cohort
Exposure Outcome Overall main effect
(Model 1)
Interaction effect with follow-
up time (Model 1a)
Main effect at 1 year
(Model 1a)
Main effect at 7 years
(Model 1a)
Overall main effect
(Model 2)
MVPA Weight − 0.07 (−0.10, − 0.03)*** − 0.0074 (−0.0145, − 0.0003)* − 0.03 (−0.08, 0.02) − 0.08 (−0.11, − 0.04)*** − 0.05 (−0.08, − 0.01)**
WC − 0.08 (−0.13, − 0.04)*** − 0.013 (−0.022, − 0.003)** − 0.02 (−0.08, 0.05) − 0.10 (−0.14, − 0.05)*** − 0.07 (−0.12, − 0.02)**
FM − 0.12 (−0.16, − 0.07)*** − 0.009 (−0.019, 0.001) − 0.072 (−0.141, − 0.003)* − 0.13 (−0.18, − 0.08)*** − 0.09 (−0.14, − 0.04)***
BF% − 0.13 (-0.18, − 0.08)*** − 0.009 (−0.020, 0.003) − 0.09 (−0.16, − 0.01)** − 0.14 (−0.19, − 0.09)*** − 0.11 (−0.17, − 0.06)***
FMI − 0.11 (-0.16, − 0.06)*** − 0.010 (−0.020, − 0.001)* − 0.06 (−0.13, 0.01) − 0.12 (−0.17, − 0.07)*** − 0.08 (−0.13, − 0.04) **
Sedentary time Weight 0.11 (0.06, 0.16)*** − 0.001 (−0.008, 0.007) 0.11 (0.05, 0.17)*** 0.10 (0.06, 0.16)*** 0.09 (0.04, 0.14)**
WC 0.06 (−0.01, 0.12) 0.003 (−0.009, 0.010) 0.06 (−0.01, 0.14) 0.06 (−0.01, 0.13) 0.03 (−0.04, 0.09)
FM 0.14 (0.08, 0.21)*** 0.003 (−0.008, 0.014) 0.13 (0.05, 0.21)** 0.15 (0.08, 0.22)*** 0.10 (0.03, 0.17)**
BF% 0.11 (0.04, 0.18)** 0.004 (−0.008, 0.016) 0.09 (0.01, 0.18)* 0.12 (0.05, 0.19)** 0.06 (−0.01, 0.13)
FMI 0.13 (0.06, 0.19)*** 0.004 (−0.007, 0.014) 0.11 (0.03, 0.19)* 0.13 (0.07, 0.20)** 0.09 (0.02, 0.16)*
Abbreviations: BF%, percentage of body fat; CI, conﬁdence interval; FM, fat mass; FMI, fat mass index (fat mass per height 2); MVPA, time spent in moderate-to-
vigorous physical activity; WC, waist circumference. Results are standardised regression coefﬁcients (95% CI), that is, the change in outcome (in s.d. units) per 1
s.d. higher value of the exposure. Model 1 adjusted for age, sex, intervention arm, monitor wear time, follow-up time, smoking status and socioeconomic
status. Model 1a: Model 1+ interaction term between exposure (MVPA or sedentary time) and follow-up time. Model 2: Model 1+ sedentary time/MVPA.
*Po0.05, **Po0.01, ***Po0.001. Data for education and/or smoking were missing for 37 participants who were therefore excluded.
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Dutch adults followed-up for 10 years, with three follow-up
assessments of PA, weight and WC. Hamer et al.39 have shown
that an increase in MVPA of 2.5 h per week or more between two
follow-ups (5 years apart) was associated with a reduction in BMI
and WC compared with stable MVPA over the same period in the
Whitehall II cohort. However, ﬁndings from the Women’s Health
Study showed an interaction between BMI and PA on weight gain,
so that the signiﬁcant inverse relationship between PA and weight
gain existed only among those with BMI o25 kgm−2 but not in
overweight or obese participants.37
Our observation that increased BF is associated with reduced
MVPA and increased SED-time is biologically plausible and can be
explained by physiological changes such as dyspnea and
musculoskeletal problems that may lead to discomfort and
subsequent drop in PA of this intensity. These results are
consistent with the ﬁndings from the EPIC-Norfolk cohort,16
showing that greater weight gain over time is associated with
physical inactivity at follow-up, as well as results from the
Copenhagen City Heart Study, indicating that higher BMI predicts
physical inactivity.17 Other studies provided evidence that greater
baseline BMI is related to later increase in SED-time based on self-
report.18–20 Only a few studies have assessed the bidirectional
character of the relationship in question and used objective
methods to measure PA. Results from the Ely Study15 suggest that
greater body weight, FM and BMI predict higher levels of SED-time
as assessed by individually calibrated heart rate monitoring.
However, the Early Bird study involving children born in 1995/96
has shown that MVPA is associated with improvements in the
composite metabolic risk score, but not with a reduction in BMI or
fatness.40 A study41 involving 785 Danish children (aged 8–11
years) demonstrated that adiposity is statistically a better
predictor of PA and SED-time than PA predicting adiposity.
Although our study has some similarities with the Danish study in
that both represent a cohort analysis of a randomised trial,
differences in age, follow-up and accelerometer wearing protocols
should be considered when making comparisons. Likewise, we
found signiﬁcant positive associations between BF and SED-time.
The observed bidirectional nature of the associations highlights
the need to consider inactivity not only as a determinant but also
as a possible result of weight gain.
The observation that follow-up time signiﬁcantly modiﬁes the
association of MVPA, but not SED-time with BF indicators may
have several explanations. It is possible that an increase in MVPA
over time leads to a decrease in BF, with the association becoming
stronger over time because of the cumulative effects of PA.
In addition, it might be that those who increase their MVPA are more
health conscious and also tend to adopt a healthier diet, thereby
leading to additional beneﬁcial effects on body composition.
An important strength of our study is the use of objective
methods to assess MVPA, SED-time and body composition in a
well-characterised population, thereby reducing the random
measurement error and recall bias associated with self-reported
PA. In addition, exposures and outcomes were measured in a
standardised fashion by trained staff at baseline and follow-ups,
which also contributed to the reduction in the random measure-
ment error. Furthermore, all exposures and outcomes of interest
were analysed in their continuous form, which decreased the
likelihood of the loss of statistical power that would have occurred
had the categorical variables been used. Mixed effects models
were performed using exposure and outcome data at all time
points that optimised statistical power and provided a framework
to take into account both the within-individual and between-
individual variance. The participants were followed-up for a
median of 7.4 years that allowed us to assess medium- to long-
term effects of MVPA and SED-time on total and abdominal
BF and vice versa. Moreover, we examined the interactions with
time and were able to quantify the exact increase in BF indices
associated with the 1 s.d. (16.8 min per day) increase in MVPA at
each time point that provides an important public health
message.
Nevertheless, several limitations need to be taken into account
in the interpretation of our results. First, the relatively small
population sample of middle-aged Caucasians at high risk for
T2DM may limit the generalisability of our ﬁndings to other
populations. Second, although we controlled for a range of
potential confounders including age, sex, cigarette smoking,
socioeconomic status, as well as monitor wear time and follow-
up time, residual confounding cannot be ruled out. In addition to
energy expenditure, energy intake is the most important factor in
determining energy balance. Dietary intake is therefore a possible
confounder in the association between MVPA, SED-time and BF,
which we were unable to include. Third, as participants were
instructed to wear the accelerometer for 4 days only, the observed
levels of PA may not be completely representative of their usual
PA. Fourth, it is possible that the validity of accelerometry for
capturing activity at various intensity levels differs by obesity
status through differential participation in different types of
activity,42,43 which may introduce bias or dilute the associations.
Although MVPA was assessed objectively, it is likely that the
measurement of MVPA over a snapshot of 4 days was less precise
Table 3. Associations between fat indicators and time spent in MVPA and sedentary obtained from mixed effects models using data at all time
points in the ProActive trial cohort
Outcome Exposure Overall main
effect (Model 1)
Interaction effect with
follow-up time (Model 1a)
Main effect at
1 year (Model 1a)
Main effect at
7 year (Model 1a)
MVPA Weight − 0.29 (−0.39; − 0.18)*** − 0.01 (−0.03, 0.01) − 0.25 (−0.38; − 0.12)*** − 0.31 (−0.43; − 0.19)***
WC − 0.25 (−0.36; − 0.15)*** − 0.01 (−0.03, 0.01) − 0.21 (−0.33; − 0.08)** − 0.28 (−0.40; − 0.17)***
FM − 0.27 (−0.36; − 0.18)*** − 0.01 (−0.04, 0.01) − 0.22 (−0.34; − 0.09)*** − 0.31 (−0.41; − 0.20)***
BF% − 0.30 (−0.41; − 0.19)*** − 0.01 (−0.03, 0.01) − 0.25 (−0.38; − 0.11)*** − 0.33 (−0.44; − 0.21)***
FMI − 0.27 (−0.36; − 0.17)*** − 0.01 (−0.03, 0.01) − 0.22 (−0.35; − 0.10)*** − 0.29 (−0.40; −0.18)***
Sedentary time Weight 0.16 (0.07; 0.25)*** 0.001 (−0.014, 0.016) 0.16 (0.06; 0.27)*** 0.17 (0.07; 0.26)***
WC 0.10 (0.02; 0.18)** 0.003 (−0.012, 0.018) 0.09 (0.01; 0.19) 0.11 (0.02; 0.20)*
FM 0.15 (0.07; 0.22)*** 0.003 (−0.011, 0.018) 0.13 (0.04; 0.23)** 0.15 (0.07; 0.24)***
BF% 0.14 (0.05; 0.22)** 0.005 (−0.010, 0.019) 0.12 (0.01; 0.22)* 0.15 (0.06; 0.24)**
FMI 0.14 (0.06; 0.22)** 0.003 (−0.012, 0.018) 0.13 (0.03; 0.24)** 0.15 (0.06; 0.23)**
Abbreviations: BF%, percentage of body fat; CI, conﬁdence interval; FM, fat mass; FMI, fat mass index (fat mass per height 2); MVPA, time spent in moderate-to-
vigorous physical activity; WC, waist circumference. Results are standardised regression coefﬁcients (95% CI), following standardisation of exposure and
outcome variables, that is, the change in outcome (in s.d. units) per 1 s.d. higher value of the exposure. Each fat indicator was included in a separate model as
exposure. Analyses were adjusted for age, sex, intervention arm, monitor wear time, follow-up time, smoking status and socioeconomic status. *Po0.05,
**Po0.01, ***Po0.001. Data for education and/or smoking were missing for 37 participants who were therefore excluded.
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than the measurement of BF. The observed greater magnitude
and wider CIs of the association in which MVPA is the outcome
compared with that in which MVPA is the exposure44 is likely
stemming from differential measurement error in MVPA and
adiposity variables, the latter being measured with greatest
relative precision; as reported by Hutcheon et al.,45 relatively
larger error in the exposure tends to attenuate an association,
whereas error in the outcome increases the standard error of an
effect estimate.
Our ﬁndings indicate that an increase in 16.8 min per day of
MVPA would result in a decrease in FM of 1.2 kg (95% CI: 0.6,
1.7) over 7 years. On the other hand, an increase in FM of 10 kg
over 7 years would result in a reduction of 4.8 min per day (95%
CI: 3.1, 6.5) in MVPA, and an increase of 0.2 h per day (95% CI:
0.1, 0.3) in SED-time. Our results corroborate considerable
beneﬁcial effects of MVPA and the detrimental effects of SED-
time on BF, which suggests that promoting an increase in
MVPA as well as a reduction SED-time would be favourable in
people with parental family history of T2DM. Our ﬁndings also
show that individuals with increased BF are more likely to
reduce their activity in the future that may have detrimental
effects on metabolic risk. Therefore, individuals with high BF
require particular attention for the promotion of MVPA and
decreasing sedentary behaviour in order to avoid self-
promoting weight gain46 and to mitigate unfavourable meta-
bolic changes because of increased BF. Our subsidiary analyses
have indicated a beneﬁcial effect of light-intensity PA on BF.
Given that adults spend a large proportion of non-sedentary
awake time at light-intensity, a detailed exploration of the role
that light-intensity PA may have in the accumulation of BF and
its association with other cardio-metabolic outcomes across a
wide range of population subgroups is warranted in future
studies.
In conclusion, our results indicate that the association of MVPA
and SED-time with total and abdominal BF is bidirectional among
individuals at high risk for T2DM. The effects of detrimental BF
proﬁle on the reduction of MVPA seem to be stronger than the
effects of increasing MVPA on a reduction in BF indices, which
suggests that BF should be regarded as a determinant of MVPA.
Given the independent effects of MVPA and sedentary behaviour,
promoting both an increase in MVPA and a decrease in sedentary
behaviour may reduce total and abdominal BF. Considering the
evidence that the beneﬁcial effects of MVPA become stronger
over time, increasing MVPA may have a greater effect than
reducing sedentary behaviour on BF. Further research is warranted
to clarify the effects of PA (including light-intensity activities) on
BF in more diverse populations.
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